there's some pretty big and important differences between those companies.and.. you couldn't buy 60 profit making practices for $17M, but you can certainly by a lot of loss making ones...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025